Home Page | LITFULO™ (ritlecitinib) | Safety Info (2024)

video_id

6354863475112

account_id

1852113022001

title

Atopic dermatitis

autoplay

true

poster

Home Page | LITFULO™ (ritlecitinib) | Safety Info (1)

video_id

6354862015112

title

Atopic dermatitis

autoplay

true

poster

Home Page | LITFULO™ (ritlecitinib) | Safety Info (2)

LITFULO is the first and only FDA-approved prescription pill for both adults and adolescents as young as 12 with severe alopecia areata.

In just under 6 months, 23% of people taking LITFULO in the clinical study saw 80% or more scalp hair coverage (vs 1.6% on placebo) and 13.4% of people taking LITFULO saw 90% or more scalp hair coverage (vs 1.5% on placebo). Individual results may vary.

style

Section-banner-homepage, padding-bottom-medium

Home Page | LITFULO™ (ritlecitinib) | Safety Info (3)

A treatment for adults, teens, and tweens ages 12+

If you’ve been living with severe alopecia areata, it’s possible to regrow hair in just under 6 months. In fact, some people taking LITFULO saw:

Significant hair regrowth that covered 80% or more of their scalp in just under 6 months.*

Some even saw this amount of regrowth in just over 4 months.


*In just under 6 months, 23% of people on LITFULO saw 80% or more scalp hair coverage (vs 1.6% on placebo) and 13.4% saw 90% or more scalp hair coverage (vs 1.5% on placebo) in the clinical study.

In just over 4 months, in 13.1% of people on LITFULO vs 1.6% on placebo in the clinical study.

In a 48-week, randomized, double-blind, placebo-controlled clinical study, participants (261 people, ages 12+, who had lost at least half of their scalp hair due to alopecia areata) took either LITFULO or placebo (an inactive pill). Safety and effectiveness have not been studied in people under 12 years of age. Results were measured at 24 weeks. Find out more information about the study.

style

padding-bottom-medium

LITFULO may cause serious side effects, including:

serious infections; increased risk of death; cancer and immune system problems; increased risk of major cardiovascular events; blood clots; allergic reactions; and changes in certain laboratory test results. For more information, talk to your doctor or learn more about the most important information about LITFULO.

See what's possible in just under 6 months with LITFULO

Clinical study photos show examples of hair regrowth observed on the scalp of actual adult or adolescent patients with alopecia areata taking LITFULO. Individual results may vary.

View Before & After photos

Home Page | LITFULO™ (ritlecitinib) | Safety Info (4) Home Page | LITFULO™ (ritlecitinib) | Safety Info (5)

Talk to a dermatologist about LITFULO

Create a personalized discussion guide that captures your experience. This can help you prepare for your next conversation with a dermatologist.

Create your guide

Pay as little as $0 for LITFULO

If eligible, sign up for savings in 2 simple steps. You can also learn more about financial assistance resources, insurance coverage, and more through Pfizer Dermatology Patient Access.

Explore your options

Make some noise for LITFULO

Are you or a loved one taking LITFULO? We'd love to hear from you! Sharing your story can help others living with this disease.

Share your story

/global/fragments/foot-note

style

No-padding-bottom

Home Page | LITFULO™ (ritlecitinib) | Safety Info (2024)
Top Articles
Latest Posts
Article information

Author: Rubie Ullrich

Last Updated:

Views: 5967

Rating: 4.1 / 5 (72 voted)

Reviews: 95% of readers found this page helpful

Author information

Name: Rubie Ullrich

Birthday: 1998-02-02

Address: 743 Stoltenberg Center, Genovevaville, NJ 59925-3119

Phone: +2202978377583

Job: Administration Engineer

Hobby: Surfing, Sailing, Listening to music, Web surfing, Kitesurfing, Geocaching, Backpacking

Introduction: My name is Rubie Ullrich, I am a enthusiastic, perfect, tender, vivacious, talented, famous, delightful person who loves writing and wants to share my knowledge and understanding with you.